Free Trial
ASX:CT1

Constellation Technologies (CT1) Stock Price, News & Analysis

Constellation Technologies logo

About Constellation Technologies Stock (ASX:CT1)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
983,646 shs
Average Volume
N/A
Market Capitalization
A$1.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CT1 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Constellation Technologies and its competitors with MarketBeat's FREE daily newsletter.

CT1 Stock News Headlines

Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
Constellation Technologies Limited
See More Headlines

CT1 Stock Analysis - Frequently Asked Questions

Constellation Technologies Limited (ASX:CT1) announced its quarterly earnings results on Thursday, February, 28th. The company reported $0.00 EPS for the quarter. Constellation Technologies had a negative net margin of 9.04% and a negative trailing twelve-month return on equity of 13.35%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Constellation Technologies investors own include Neuren Pharmaceuticals (NEU), Macquarie Group (MQG), Magellan Financial Group (MFG), Medlab Clinical (MDC), FBR (FBR), Embark Early Education (EVO) and Dreadnought Resources (DRE).

Company Calendar

Last Earnings
2/28/2019
Today
7/04/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Information Technology Services
Sub-Industry
N/A
Current Symbol
ASX:CT1
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$1.35 million
Price / Cash Flow
5.63
Book Value
A$0.00 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,470,000,000
Free Float
N/A
Market Cap
A$1.47 million
Optionable
Not Optionable
Beta
1.40
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (ASX:CT1) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners